UNR Office of Human Research Protection

Home

Policy

How to Submit

Forms

Schedule

Training

Contact Us

 

Submit all applications to the UNR OHRP at 205 Ross Hall / 331, University of Nevada, Reno, Reno, NV 89557

(775) 327-2368

(775) 327-2369 FAX

 

Policies and Procedures for Human Research Protection

August 28, 2006

1      Mission. 6

1.1       Introduction. 6

1.2       Ethical Principles: The Belmont Report 7

2      Definitions. 8

3      Institutional Authority. 8

3.1       Assurance of Compliance [45 CFR 46.103] 8

3.2       UNR Office of Human Research Protection (UNR OHRP) 8

3.3       Nevada State Law.. 8

4      UNR Institutional Review Boards (IRBs) 8

4.1       Authority of the IRBs. 8

4.2       Jurisdiction of the IRB.. 8

4.3       IRB Relationships. 8

4.4       Roles and Responsibilities. 8

4.4.1        Chair of the IRB.. 8

4.4.2        Vice Chair of the IRB.. 8

4.4.3        Subcommittees of the IRB.. 8

4.5       Resources for IRBs. 8

4.6       Conduct of Quality Assurance/Quality Improvement Activities for IRB Operation. 8

5      IRB Membership. 8

5.1       Composition of the IRBs. 8

5.2       Appointment of Members to the IRB.. 8

5.3       Use of Consultants (Outside Reviewers) 8

5.4       Duties of IRB Members. 8

5.5       Attendance Requirements. 8

5.6       Training / Ongoing Education of Chair and IRB Members in Regulations, Procedures  8

5.7       Liability Coverage for IRB Members. 8

5.8       Review of IRB Member Performance. 8

6      IRB Records. 8

6.1       Minutes of an IRB Meeting. 8

6.2       Membership Rosters. 8

6.3       Records Retention Requirements. 8

6.4       Written Procedures and Guidelines. 8

7      IRB Review Process. 8

7.1       Human Subjects Research Determination. 8

7.2       Exempt Research. 8

7.2.1        Categories of Research Permissible for Exemption. 8

7.2.2        FDA Exemptions. 8

7.2.4 Additional Protections. 8

7.3       IRB Meetings. 8

7.3.1        Schedule of IRB Meetings. 8

7.3.2        Quorum.. 8

7.3.3        New Protocol Applications. 8

7.3.4        Pre-Meeting Distribution of Documents. 8

7.3.5        Post-Meeting Distribution of Documents. 8

7.3.6        Conflicts of Interest 8

7.3.6.1 IRB Member Conflicts of Interest 8

7.3.6.2     Investigator Conflicts of Interest Error! Bookmark not defined.

7.3.6.2.1      General Conflict Management 8

7.3.6.2.2      Protocol-Specific Conflict Management 8

7.3.7        Sponsored Research Contracts. 8

7.3.8        Possible IRB Actions Taken by Vote. 8

7.3.9        Determination of Risk. 8

7.3.10      Period of Approval 8

7.3.11      Review More Often Than Annually. 8

7.3.12      Independent Verification Regarding Material Changes. 8

7.3.13      Consent Monitoring. 8

7.3.15  Reporting IRB Actions. 8

7.4       Continuing Review of Active Protocols (Renewals) 8

7.4.1        Continuing Review Process. 8

7.4.2        Expedited Review of Continuing Review.. 8

7.4.3        How is the Continuing Review Date Determined?. 8

7.4.4        What Occurs if There is a Lapse in Continuing Review?. 8

7.4.5        Studies that are Approved but Never Started. 8

7.5       Modification of an Approved Protocol 8

7.6       Unanticipated Problems and Adverse Events. 8

7.6.1        Definitions. 8

7.6.1.1     Unanticipated Problems. 8

7.6.1.2     Adverse Events. 8

7.6.1.3     Relating Adverse Events to Unanticipated Problems. 8

7.6.2        Reporting. 8

7.6.2.1     Principal Investigator Responsibilities. 8

7.6.2.1.1      Internal Adverse Events. 8

7.6.2.1.2      External Adverse Events. 8

7.6.2.1.3      Other Unanticipated Problems (not related to adverse events) 8

7.6.3        IRB Review of Unanticipated Problems and Adverse Events. 8

7.7       Expedited Review of Research. 8

7.7.1        Categories of Research Eligible for Expedited Review.. 8

7.8       Research Involving an Investigational Drug or Device. 8

7.8.1        Emergency Treatment with an IND or IDE.. 8

7.8.2        Exception from Informed Consent for Planned Emergency Research. 8

7.8.3        Humanitarian Use Device (HUD) 8

7.9       Further Review/Approval of IRB Actions by Others within the Institution. 8

7.10     Initiation of Research Projects. 8

7.11     Appeal of IRB Decisions. 8

7.12     Protocol Processing Fees. 8

8      Criteria for IRB Approval of Research. 8

8.1       Risk/Benefit Assessment 8

8.1.1        Scientific Merit 8

8.2       Selection of subjects is equitable. 8

8.2.1        Recruitment of Subject 8

8.3       Informed Consent 8

8.4       Data Safety Monitoring. 8

8.5       Privacy and Confidentiality. 8

8.6       Vulnerable Populations. 8

9      Informed Consent 8

9.1       Informed Consent Process. 8

9.2       Elements of Informed Consent 8

9.3       Waiver of Informed Consent 8

9.4       Documentation of Informed Consent (Signed Consent) 8

9.5       Waiver of Documentation of Informed Consent (Waiver of Signed Consent) 8

9.6       Review and Approval of the Informed Consent Form.. 8

9.7       Parental Permission and Assent 8

9.8       Surrogate Consent 8

9.9       Consent and Language Barriers. 8

10        Vulnerable Populations. 8

10.1     Research Involving Children. 8

10.1.1      Definitions. 8

10.1.2      Allowable Categories. 8

10.1.3      Parental Permission and Assent 8

10.1.3.1       Parental Permission. 8

10.1.3.2       Assent from Children. 8

10.1.3.3       Children Who are Wards. 8

10.2     Research Involving Pregnant Women, Human Fetuses and Neonates. 8

10.2.1      Definitions. 8

10.2.2      Research Involving Pregnant Women or Fetuses. 8

10.2.3      Research involving neonates. 8

10.2.4      Research Involving, After Delivery, the Placenta, the Dead Fetus or Fetal Material 8

10.2.5      Research Not Otherwise Approvable. 8

10.3     Research Involving Prisoners. 8

10.3.1      Applicability. 8

10.3.2      Purpose. 8

10.3.3      Definitions. 8

10.3.4      Composition of the IRB.. 8

10.3.5      Additional Duties of the IRB.. 8

10.3.6      Waiver for Epidemiology Research. 8

10.4     Persons with Mental Disabilities or Persons with Impaired Decision-Making Capacity  8

10.4.1      IRB composition. 8

10.4.2      Approval Criteria. 8

10.4.3      Additional Concerns. 8

11        Complaints, Non-compliance, and Suspension or Termination of IRB Approval of Research  8

11.1     Complaints. 8

11.2     Non-compliance. 8

11.2.1      Definitions. 8

11.2.2      Review of Allegations of Non-compliance. 8

11.2.3      Review of Findings of Non-compliance. 8

11.2.4      Inquiry Procedures. 8

11.2.5      Final Review.. 8

11.2.6      Additional Actions. 8

11.3     Suspension or Termination. 8

11.4     Reporting. 8

12        Reporting to Regulatory Agencies and Institutional Officials. 8

13        Investigator Responsibilities. 8

13.1     Investigators. 8

13.2     Protocol Development 8

13.3     Changes to Approved Research. 8

13.4     Continuing Review after Protocol Approval 8

13.5     Required Reports to the IRB.. 8

13.5.1      Unanticipated Problems. 8

13.5.2      Complaints, Non-compliance and Protocol Deviations. 8

13.5.3      Progress Reports. 8

13.6     Investigator-Required Record Keeping. 8

13.7     Conflict of Interest – Investigators. 8

13.8     Training / Ongoing Education of Principal Investigator and Research Team.. 8

13.9     Subject Recruitment 8

13.10       Payment to Subjects. 8

13.11       Investigator Concerns. 8

14        Health Insurance Portability and Accountability Act (HIPAA) 8

14.1     Historical Background. 8

14.2     Effects of HIPAA on Research. 8

15        Special Topics. 8

15.1     Certificate of Confidentiality. 8

15.2     Mandatory Reporting. 8

15.3     UNR Students and Employees as Subjects. 8

15.4     Psychology Department Subject Pool 8

15.5     Student Research. 8

15.5.1      Class projects. 8

15.5.2      Independent Study, Theses and Dissertations. 8

15.6     Oral History. 8

15.7     Genetic Studies. 8

15.8     Research Involving Coded Private Information or Biological Specimens. 8

15.8.1      Collection, Processing and/or Banking of Human Research Subjects’ Specimens at the VA Sierra Nevada Health Care System (VASNHCS) 8

 

 


1 Mission

The University of Nevada, Reno (UNR) fosters a research environment that promotes the respect for the rights and welfare of individuals recruited for, or participating in, research conducted by or under the auspices of the University, including the University of Nevada School of Medicine (UNSOM). In the review and conduct of research, actions by the UNR and the UNSOM will be guided by the principles (i.e., respect for persons, beneficence, and justice) set forth in the Ethical Principles and Guidelines for the Protection of Human Subjects of Research (often referred to as the Belmont Report) and will performed in accordance with the Department of Health and Human Services (HHS) policy, and regulations at 45 CFR 46 (also known as the “Common Rule”), and the Food and Drug Administration (FDA) policy, and regulations at 21 CFR 50 and 21 CFR 56. Additionally, to honor its commitment to the VA Sierra Nevada Health Care System, the University abides by the Department of Veterans Affairs policies for human research protection, including the regulations at 38 CFR 16, and the VHA Handbook 1200.5. The actions of UNR will also conform to all other applicable federal, State, and local laws and regulations.